|Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure|
VG Florea, MY Henein, SD Anker, DP Francis, JS Chambers, ...
European heart journal 21 (2), 146-153, 2000
|Shuttle-walk test to assess chronic heart failure|
SD Keell, JS Chambers, DP Francis, DF Edwards, RH Stables
The Lancet 352 (9129), 705, 1998
|Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure.|
TP Chua, PP Ponikowski, D Harrington, J Chambers, AJ Coats
Heart 76 (6), 483-489, 1996
|Dyspnoea and exercise intolerance during cardiopulmonary exercise testing in patients with univentricular heart: the effects of chronic hypoxaemia and Fontan procedure|
L Iserin, TP Chua, J Chambers, AJS Coats, J Somerville
European heart journal 18 (8), 1350-1356, 1997
|An open label phase II trial of BI 2536, a novel Plk1 inhibitor, in patients with metastatic hormone refractory prostate cancer (HRPC)|
HS Pandha, A Protheroe, J Wylie, C Parker, J Chambers, S Bell, ...
Journal of Clinical Oncology 26 (15_suppl), 14547-14547, 2008
|Pulmonary response of normal human subjects to inhaled vasodilator substances|
SJ Brett, J Chambers, A Bush, M Rosenthal, TW Evans
Clinical Science 95 (5), 621-627, 1998
|Superiority of endothelin-1 over norepinephrine in exercise-induced alterations of the conduit artery tone of the non-exercised arm in patients with chronic heart failure|
M Yousufuddin, W Shamim, JS Chambers, M Henein, FR Amin, SD Anker, ...
International journal of cardiology 73 (1), 15-25, 2000
|Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3)|
J Chambers, N Reed, W Mansoor, P Ross, A Grossman
Regulatory Peptides 164 (1), 6-7, 2010
|Naloxegol for patients with cancer pain diagnosed with opioid induced constipation (OIC): NACASY observational study.|
A Davies, J Tack, A Fernandez, J Chambers
Journal of Clinical Oncology 38 (ASCO abstract e19350), 2020
|Similarities between exercise capacity and ventilation in patients with mitochondrial myopathy and chronic heart failure|
D Harrington, JS Chambers, SD Anker, J Morgan-Hughes, ...
Journal of the American College of Cardiology 31, 331-331, 1998
|Real-life evaluation of budesonide/formoterol (DuoResp Spiromax®) for the management of asthma and COPD in the UK.|
JV Nicolas Roche, Hitcham Benhaddi, Marianka van der Toll, Jonathan Chambers ...
European Respiratory Journal, 2017
|Afinitor UK particular patient supplies for advanced neuroendocrine tumours.|
Neuroendocrinology 94 (Suppl. 1), 13, 2011
|Preliminary Report of the Use of Everolimus in a Patient with Progressive Medullary Thyroid Carcinoma|
M Druce, K Maher, S Grozinsky-Glasberg, D Gross, J Chambers, ...
|Everolimus (RAD001) compassionate supplies programme|
Regulatory Peptides 1 (164), 10, 2010
|VE/VCO2 slope and peak VO2 interact and define a non-linear prognostic" risk surface" in chronic heart failure|
DP Francis, W Shamim, LC Davies, JS Chambers, SD Anker, AJS Coats
Heart 81 (SUPPL. 1), 1999